Semantic search

Human (Homo sapiens)

• 10399-106A3 (acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh))
• 10400-106A4 (acute myeloid leukemia (FAB M5) cell line:THP-1 (revived))
• 10405-106A9 (acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed))
• 11224-116B9 (CD14+ Monocytes, donor1)
• 11229-116C5 (CD14+ monocyte derived endothelial progenitor cells, donor1)
• 11305-117B9 (CD14+ Monocytes, donor2)
• 11310-117C5 (CD14+ monocyte derived endothelial progenitor cells, donor2)
• 11381-118B4 (CD14+ Monocytes, donor3)
• 11386-118B9 (CD14+ monocyte derived endothelial progenitor cells, donor3)
• 11788-124B6 (CD14+CD16- Monocytes, donor1)
• 11789-124B7 (CD14+CD16+ Monocytes, donor1)
• 11790-124B8 (CD14-CD16+ Monocytes, donor1)
• 11799-124C8 (CD14+CD16- Monocytes, donor2)
• 11800-124C9 (CD14-CD16+ Monocytes, donor2)
• 11801-124D1 (CD14+CD16+ Monocytes, donor2)
• 11857-125A3
• 11858-125A4
• 11859-125A5
• 11860-125A6 (CD14+ monocytes - treated with BCG, donor1)
• 11861-125A7 (CD14+ monocytes - treated with IFN + N-hexane, donor1)
• 11862-125A8 (CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1)
• 11863-125A9 (CD14+ monocytes - mock treated, donor1)
• 11864-125B1 (CD14+ monocytes - treated with Group A streptococci, donor1)
• 11865-125B2 (CD14+ monocytes - treated with lipopolysaccharide, donor1)
• 11866-125B3 (CD14+ monocytes - treated with Salmonella, donor1)
• 11867-125B4 (CD14+ monocytes - treated with Cryptococcus, donor1)
• 11868-125B5 (CD14+ monocytes - treated with Candida, donor1)
• 11869-125B6 (CD14+ monocytes - treated with B-glucan, donor1)
• 11870-125B7 (CD14+ monocytes - treated with BCG, donor2)
• 11871-125B8 (CD14+ monocytes - treated with IFN + N-hexane, donor2)
• 11872-125B9 (CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2)
• 11873-125C1 (CD14+ monocytes - mock treated, donor2)
• 11874-125C2 (CD14+ monocytes - treated with Group A streptococci, donor2)
• 11875-125C3 (CD14+ monocytes - treated with lipopolysaccharide, donor2)
• 11876-125C4 (CD14+ monocytes - treated with Salmonella, donor2)
• 11877-125C5 (CD14+ monocytes - treated with Cryptococcus, donor2)
• 11878-125C6 (CD14+ monocytes - treated with Candida, donor2)
• 11879-125C7 (CD14+ monocytes - treated with B-glucan, donor2)
• 11880-125C8 (CD14+ monocytes - treated with BCG, donor3)
• 11881-125C9 (CD14+ monocytes - treated with IFN + N-hexane, donor3)
• 11882-125D1 (CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3)
• 11883-125D2 (CD14+ monocytes - mock treated, donor3)
• 11884-125D3 (CD14+ monocytes - treated with Group A streptococci, donor3)
• 11885-125D4 (CD14+ monocytes - treated with lipopolysaccharide, donor3)
• 11886-125D5 (CD14+ monocytes - treated with Salmonella, donor3)
• 11887-125D6 (CD14+ monocytes - treated with Cryptococcus, donor3)
• 11888-125D7 (CD14+ monocytes - treated with Candida, donor3)
• 11889-125D8 (CD14+ monocytes - treated with B-glucan, donor3)
• 11910-125G2 (CD14+CD16- Monocytes, donor3)
• 11911-125G3 (CD14-CD16+ Monocytes, donor3)